Biotech entity
Every one of those 5 sits in a single category, pharma. Against the same-window beat baseline of 19% negative, this entity's 100% share is more negative. That works out to roughly 1.9 stories per week across an 18-day span. The busiest single day carried 2.
Last mentioned: Jul 18, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 5 sits in a single category, pharma. Against the same-window beat baseline of 19% negative, this entity's 100% share is more negative. That works out to roughly 1.9 stories per week across an 18-day span. The busiest single day carried 2. Of the tracked stories, 2 of 5 also mention EMA, the most common co-covered peer. At 7.4, the average consequence score sits above the same-window beat average of 6.1. Source depth averages 4.2 original sources per story, versus 3.4 across the same-window beat baseline. We currently track 5 Biotech stories that mention Iran, published between March 4, 2026 and March 21, 2026.
Computed from the 5 stories linked to this entity, with beat comparisons drawn from all 268 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Iran. Shared-story counts are live from our verified record — not editorial picks.
Critical Reserve Review
U.S. and European health agencies expected to review emergency helium reserves for medical use.
Price Surge
Spot prices for liquid helium projected to rise by 40-60% in global markets.
Supply Chain Alert
Major industrial gas distributors issue warnings of potential force majeure to healthcare clients.
Production Halt
Qatari helium facilities suspend operations as regional conflict with Iran escalates.
Industry Advisory
Cybersecurity experts urge healthcare and MedTech firms to audit external-facing assets and supply chain partners.
Public Disclosure
Multiple news outlets report on the breach and expert warnings of further attacks targeting the sector.
Gas Rationing Implemented
Adani Total Gas limits supply to 40% of contracted quantity for medical device producers.
Attribution Identified
Security researchers at Microsoft identify signatures linked to Iranian-backed threat actors.
Initial Detection
Stryker security teams identify unauthorized access to internal corporate networks.
Price Warnings
Industry analysts and news outlets report imminent drug price hikes due to sustained supply chain pressure.
Price Surge Acceleration
Raw material costs spike 25-35% within a 10-day window following escalated conflict.
Shipping Diversions
Major logistics firms like Maersk and MSC begin rerouting vessels away from the Strait of Hormuz.
Conflict Escalation
Initial military activities in the Iran region lead to maritime security alerts.
Initial Price Creep
Polypropylene prices begin a steady climb as Middle East tensions simmer.
The suspension of helium production in Qatar due to escalating regional conflict with Iran has triggered an immediate crisis for the global healthcare and pharmaceutical sectors. As a primary coolant for MRI machines and a vital component in drug discovery research, the loss of Qatari supply threatens to disrupt diagnostic services and clinical development timelines worldwide.
A significant cyberattack targeting medical technology giant Stryker has been linked to Iranian-backed threat actors, prompting urgent warnings for the broader healthcare industry. Security experts indicate this breach may be part of a wider campaign aimed at disrupting critical infrastructure and stealing intellectual property within the U.S. medical sector.
Source: wcyb.com
A critical shortage of medical consumables is looming in India as the Iran war triggers a 35% surge in polypropylene prices and severe gas rationing. These disruptions threaten the production of essential items like syringes and IV bags, primarily impacting the small and medium enterprises that dominate the sector.
Escalating geopolitical tensions involving Iran have triggered a high-alert status across the global pharmaceutical industry as critical supply routes face potential closure. The conflict threatens the transit of active pharmaceutical ingredients (APIs) and medical electronics, forcing manufacturers to brace for significant delays and rising costs.
Military conflict in Iran has destabilized critical maritime routes, leading to a surge in logistics costs for life-saving medications. As active pharmaceutical ingredient (API) shipments face delays and rising insurance premiums, the industry braces for a period of significant price volatility and potential shortages.
Iran is linked from 5 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
